Loading company…
Watchmaker Genomics develops enzymes and kits for sequencing, synthetic biology and molecular diagnostics.
Founded in 2019, Watchmaker Genomics applies enzyme technology to DNA research and develops products for clinical genomics. Its portfolio includes enzymes and kits for next-generation sequencing, synthetic biology and molecular diagnostics. The company is based in Boulder, US, and was founded by Trey Foskett. In June 2022, it raised USD 40 million in Series A funding led by Decheng Capital, with participation from Eclipse Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in